… of Parkinson's disease, including environmental and genetic origins. Future elucidation of
the disease process in Parkinson's disease may yield obvious therapeutic … disease. These …

… Here, we review the potential of autophagy enhancement as disease-modifying therapy
in PD based on preclinical evidence. In particular, we provide an overview of the molecular …

… HDACIs in cellular and animal models of Parkinsonian cell death. Ultimately answering the
question: does epigenetic targeting of histone deacetylases hold therapeutic potential in PD? …

… In the field of neurodegenerative disease, it is becoming increasingly common for the
therapeutic potential of drugs already licenced for other conditions to be explored (so-called “drug …

In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A 2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

The central objective in treating patients with Parkinson's disease (PD) is two-fold (i) to
increase the striatal dopamine content and (ii) to prevent further degeneration of the surviving …

Parkinson’s disease (PD) is a multifactorial disorder, attributed to a complex interplay between
genetic and epigenetic factors. Although the exact etiology of the disease remains elusive…

… therapeutic ability has not been addressed fully. In the current study, we investigated the
therapeutic potential of … that striatal transplanted iNSCs may have therapeutic potential for PD. …

… Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common age-related …
diseases. However, in some overlapping cases, known as Alzheimer with Parkinson disease …

… potential therapeutic target in neurodegenerative diseases [11, 12, 20, 29-33]. The purpose
of this review is to highlight potential mechanisms and evidence for the therapeutic … potential …